Global Aflibercept Drug Market Growth 2023-2029

March 2023 | 72 pages | ID: G105DCFB45EAEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Aflibercept, sold under the brand names Eylea and Zaltrap, is a medication used to treat wet macular degeneration and metastatic colorectal cancer.

LPI (LP Information)' newest research report, the “Aflibercept Drug Industry Forecast” looks at past sales and reviews total world Aflibercept Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Aflibercept Drug sales for 2023 through 2029. With Aflibercept Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Aflibercept Drug industry.

This Insight Report provides a comprehensive analysis of the global Aflibercept Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Aflibercept Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Aflibercept Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Aflibercept Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Aflibercept Drug.

The global Aflibercept Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Aflibercept Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Aflibercept Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Aflibercept Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Aflibercept Drug players cover Regeneron, Bayer and Sanofi, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Aflibercept Drug market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• Prefilled Syring Package
• Vial Package

Segmentation by application

• Eye Disease
• Cancer

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Regeneron
• Bayer
• Sanofi

Key Questions Addressed in this Report

What is the 10-year outlook for the global Aflibercept Drug market?

What factors are driving Aflibercept Drug market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Aflibercept Drug market opportunities vary by end market size?

How does Aflibercept Drug break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Aflibercept Drug Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Aflibercept Drug by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Aflibercept Drug by Country/Region, 2018, 2022 & 2029
2.2 Aflibercept Drug Segment by Type
  2.2.1 Prefilled Syring Package
  2.2.2 Vial Package
2.3 Aflibercept Drug Sales by Type
  2.3.1 Global Aflibercept Drug Sales Market Share by Type (2018-2023)
  2.3.2 Global Aflibercept Drug Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Aflibercept Drug Sale Price by Type (2018-2023)
2.4 Aflibercept Drug Segment by Application
  2.4.1 Eye Disease
  2.4.2 Cancer
2.5 Aflibercept Drug Sales by Application
  2.5.1 Global Aflibercept Drug Sale Market Share by Application (2018-2023)
  2.5.2 Global Aflibercept Drug Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Aflibercept Drug Sale Price by Application (2018-2023)

3 GLOBAL AFLIBERCEPT DRUG BY COMPANY

3.1 Global Aflibercept Drug Breakdown Data by Company
  3.1.1 Global Aflibercept Drug Annual Sales by Company (2018-2023)
  3.1.2 Global Aflibercept Drug Sales Market Share by Company (2018-2023)
3.2 Global Aflibercept Drug Annual Revenue by Company (2018-2023)
  3.2.1 Global Aflibercept Drug Revenue by Company (2018-2023)
  3.2.2 Global Aflibercept Drug Revenue Market Share by Company (2018-2023)
3.3 Global Aflibercept Drug Sale Price by Company
3.4 Key Manufacturers Aflibercept Drug Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Aflibercept Drug Product Location Distribution
  3.4.2 Players Aflibercept Drug Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR AFLIBERCEPT DRUG BY GEOGRAPHIC REGION

4.1 World Historic Aflibercept Drug Market Size by Geographic Region (2018-2023)
  4.1.1 Global Aflibercept Drug Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Aflibercept Drug Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Aflibercept Drug Market Size by Country/Region (2018-2023)
  4.2.1 Global Aflibercept Drug Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Aflibercept Drug Annual Revenue by Country/Region (2018-2023)
4.3 Americas Aflibercept Drug Sales Growth
4.4 APAC Aflibercept Drug Sales Growth
4.5 Europe Aflibercept Drug Sales Growth
4.6 Middle East & Africa Aflibercept Drug Sales Growth

5 AMERICAS

5.1 Americas Aflibercept Drug Sales by Country
  5.1.1 Americas Aflibercept Drug Sales by Country (2018-2023)
  5.1.2 Americas Aflibercept Drug Revenue by Country (2018-2023)
5.2 Americas Aflibercept Drug Sales by Type
5.3 Americas Aflibercept Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Aflibercept Drug Sales by Region
  6.1.1 APAC Aflibercept Drug Sales by Region (2018-2023)
  6.1.2 APAC Aflibercept Drug Revenue by Region (2018-2023)
6.2 APAC Aflibercept Drug Sales by Type
6.3 APAC Aflibercept Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Aflibercept Drug by Country
  7.1.1 Europe Aflibercept Drug Sales by Country (2018-2023)
  7.1.2 Europe Aflibercept Drug Revenue by Country (2018-2023)
7.2 Europe Aflibercept Drug Sales by Type
7.3 Europe Aflibercept Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Aflibercept Drug by Country
  8.1.1 Middle East & Africa Aflibercept Drug Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Aflibercept Drug Revenue by Country (2018-2023)
8.2 Middle East & Africa Aflibercept Drug Sales by Type
8.3 Middle East & Africa Aflibercept Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Aflibercept Drug
10.3 Manufacturing Process Analysis of Aflibercept Drug
10.4 Industry Chain Structure of Aflibercept Drug

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Aflibercept Drug Distributors
11.3 Aflibercept Drug Customer

12 WORLD FORECAST REVIEW FOR AFLIBERCEPT DRUG BY GEOGRAPHIC REGION

12.1 Global Aflibercept Drug Market Size Forecast by Region
  12.1.1 Global Aflibercept Drug Forecast by Region (2024-2029)
  12.1.2 Global Aflibercept Drug Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Aflibercept Drug Forecast by Type
12.7 Global Aflibercept Drug Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Regeneron
  13.1.1 Regeneron Company Information
  13.1.2 Regeneron Aflibercept Drug Product Portfolios and Specifications
  13.1.3 Regeneron Aflibercept Drug Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Regeneron Main Business Overview
  13.1.5 Regeneron Latest Developments
13.2 Bayer
  13.2.1 Bayer Company Information
  13.2.2 Bayer Aflibercept Drug Product Portfolios and Specifications
  13.2.3 Bayer Aflibercept Drug Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Bayer Main Business Overview
  13.2.5 Bayer Latest Developments
13.3 Sanofi
  13.3.1 Sanofi Company Information
  13.3.2 Sanofi Aflibercept Drug Product Portfolios and Specifications
  13.3.3 Sanofi Aflibercept Drug Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Sanofi Main Business Overview
  13.3.5 Sanofi Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Aflibercept Drug Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Aflibercept Drug Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Prefilled Syring Package
Table 4. Major Players of Vial Package
Table 5. Global Aflibercept Drug Sales by Type (2018-2023) & (K Units)
Table 6. Global Aflibercept Drug Sales Market Share by Type (2018-2023)
Table 7. Global Aflibercept Drug Revenue by Type (2018-2023) & ($ million)
Table 8. Global Aflibercept Drug Revenue Market Share by Type (2018-2023)
Table 9. Global Aflibercept Drug Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Aflibercept Drug Sales by Application (2018-2023) & (K Units)
Table 11. Global Aflibercept Drug Sales Market Share by Application (2018-2023)
Table 12. Global Aflibercept Drug Revenue by Application (2018-2023)
Table 13. Global Aflibercept Drug Revenue Market Share by Application (2018-2023)
Table 14. Global Aflibercept Drug Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Aflibercept Drug Sales by Company (2018-2023) & (K Units)
Table 16. Global Aflibercept Drug Sales Market Share by Company (2018-2023)
Table 17. Global Aflibercept Drug Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Aflibercept Drug Revenue Market Share by Company (2018-2023)
Table 19. Global Aflibercept Drug Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Aflibercept Drug Producing Area Distribution and Sales Area
Table 21. Players Aflibercept Drug Products Offered
Table 22. Aflibercept Drug Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Aflibercept Drug Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Aflibercept Drug Sales Market Share Geographic Region (2018-2023)
Table 27. Global Aflibercept Drug Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Aflibercept Drug Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Aflibercept Drug Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Aflibercept Drug Sales Market Share by Country/Region (2018-2023)
Table 31. Global Aflibercept Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Aflibercept Drug Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Aflibercept Drug Sales by Country (2018-2023) & (K Units)
Table 34. Americas Aflibercept Drug Sales Market Share by Country (2018-2023)
Table 35. Americas Aflibercept Drug Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Aflibercept Drug Revenue Market Share by Country (2018-2023)
Table 37. Americas Aflibercept Drug Sales by Type (2018-2023) & (K Units)
Table 38. Americas Aflibercept Drug Sales by Application (2018-2023) & (K Units)
Table 39. APAC Aflibercept Drug Sales by Region (2018-2023) & (K Units)
Table 40. APAC Aflibercept Drug Sales Market Share by Region (2018-2023)
Table 41. APAC Aflibercept Drug Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Aflibercept Drug Revenue Market Share by Region (2018-2023)
Table 43. APAC Aflibercept Drug Sales by Type (2018-2023) & (K Units)
Table 44. APAC Aflibercept Drug Sales by Application (2018-2023) & (K Units)
Table 45. Europe Aflibercept Drug Sales by Country (2018-2023) & (K Units)
Table 46. Europe Aflibercept Drug Sales Market Share by Country (2018-2023)
Table 47. Europe Aflibercept Drug Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Aflibercept Drug Revenue Market Share by Country (2018-2023)
Table 49. Europe Aflibercept Drug Sales by Type (2018-2023) & (K Units)
Table 50. Europe Aflibercept Drug Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Aflibercept Drug Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Aflibercept Drug Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Aflibercept Drug Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Aflibercept Drug Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Aflibercept Drug Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Aflibercept Drug Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Aflibercept Drug
Table 58. Key Market Challenges & Risks of Aflibercept Drug
Table 59. Key Industry Trends of Aflibercept Drug
Table 60. Aflibercept Drug Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Aflibercept Drug Distributors List
Table 63. Aflibercept Drug Customer List
Table 64. Global Aflibercept Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Aflibercept Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Aflibercept Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Aflibercept Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Aflibercept Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Aflibercept Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Aflibercept Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Aflibercept Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Aflibercept Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Aflibercept Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Aflibercept Drug Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Aflibercept Drug Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Aflibercept Drug Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Aflibercept Drug Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Regeneron Basic Information, Aflibercept Drug Manufacturing Base, Sales Area and Its Competitors
Table 79. Regeneron Aflibercept Drug Product Portfolios and Specifications
Table 80. Regeneron Aflibercept Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Regeneron Main Business
Table 82. Regeneron Latest Developments
Table 83. Bayer Basic Information, Aflibercept Drug Manufacturing Base, Sales Area and Its Competitors
Table 84. Bayer Aflibercept Drug Product Portfolios and Specifications
Table 85. Bayer Aflibercept Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Bayer Main Business
Table 87. Bayer Latest Developments
Table 88. Sanofi Basic Information, Aflibercept Drug Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanofi Aflibercept Drug Product Portfolios and Specifications
Table 90. Sanofi Aflibercept Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Sanofi Main Business
Table 92. Sanofi Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Aflibercept Drug
Figure 2. Aflibercept Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Aflibercept Drug Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Aflibercept Drug Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Aflibercept Drug Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Prefilled Syring Package
Figure 10. Product Picture of Vial Package
Figure 11. Global Aflibercept Drug Sales Market Share by Type in 2022
Figure 12. Global Aflibercept Drug Revenue Market Share by Type (2018-2023)
Figure 13. Aflibercept Drug Consumed in Eye Disease
Figure 14. Global Aflibercept Drug Market: Eye Disease (2018-2023) & (K Units)
Figure 15. Aflibercept Drug Consumed in Cancer
Figure 16. Global Aflibercept Drug Market: Cancer (2018-2023) & (K Units)
Figure 17. Global Aflibercept Drug Sales Market Share by Application (2022)
Figure 18. Global Aflibercept Drug Revenue Market Share by Application in 2022
Figure 19. Aflibercept Drug Sales Market by Company in 2022 (K Units)
Figure 20. Global Aflibercept Drug Sales Market Share by Company in 2022
Figure 21. Aflibercept Drug Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Aflibercept Drug Revenue Market Share by Company in 2022
Figure 23. Global Aflibercept Drug Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Aflibercept Drug Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Aflibercept Drug Sales 2018-2023 (K Units)
Figure 26. Americas Aflibercept Drug Revenue 2018-2023 ($ Millions)
Figure 27. APAC Aflibercept Drug Sales 2018-2023 (K Units)
Figure 28. APAC Aflibercept Drug Revenue 2018-2023 ($ Millions)
Figure 29. Europe Aflibercept Drug Sales 2018-2023 (K Units)
Figure 30. Europe Aflibercept Drug Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Aflibercept Drug Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Aflibercept Drug Revenue 2018-2023 ($ Millions)
Figure 33. Americas Aflibercept Drug Sales Market Share by Country in 2022
Figure 34. Americas Aflibercept Drug Revenue Market Share by Country in 2022
Figure 35. Americas Aflibercept Drug Sales Market Share by Type (2018-2023)
Figure 36. Americas Aflibercept Drug Sales Market Share by Application (2018-2023)
Figure 37. United States Aflibercept Drug Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Aflibercept Drug Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Aflibercept Drug Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Aflibercept Drug Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Aflibercept Drug Sales Market Share by Region in 2022
Figure 42. APAC Aflibercept Drug Revenue Market Share by Regions in 2022
Figure 43. APAC Aflibercept Drug Sales Market Share by Type (2018-2023)
Figure 44. APAC Aflibercept Drug Sales Market Share by Application (2018-2023)
Figure 45. China Aflibercept Drug Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Aflibercept Drug Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Aflibercept Drug Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Aflibercept Drug Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Aflibercept Drug Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Aflibercept Drug Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Aflibercept Drug Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Aflibercept Drug Sales Market Share by Country in 2022
Figure 53. Europe Aflibercept Drug Revenue Market Share by Country in 2022
Figure 54. Europe Aflibercept Drug Sales Market Share by Type (2018-2023)
Figure 55. Europe Aflibercept Drug Sales Market Share by Application (2018-2023)
Figure 56. Germany Aflibercept Drug Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Aflibercept Drug Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Aflibercept Drug Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Aflibercept Drug Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Aflibercept Drug Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Aflibercept Drug Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Aflibercept Drug Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Aflibercept Drug Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Aflibercept Drug Sales Market Share by Application (2018-2023)
Figure 65. Egypt Aflibercept Drug Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Aflibercept Drug Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Aflibercept Drug Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Aflibercept Drug Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Aflibercept Drug Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Aflibercept Drug in 2022
Figure 71. Manufacturing Process Analysis of Aflibercept Drug
Figure 72. Industry Chain Structure of Aflibercept Drug
Figure 73. Channels of Distribution
Figure 74. Global Aflibercept Drug Sales Market Forecast by Region (2024-2029)
Figure 75. Global Aflibercept Drug Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Aflibercept Drug Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Aflibercept Drug Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Aflibercept Drug Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Aflibercept Drug Revenue Market Share Forecast by Application (2024-2029)